Free Trial

Penumbra (PEN) Competitors

Penumbra logo
$268.45 +4.76 (+1.80%)
Closing price 03:59 PM Eastern
Extended Trading
$268.38 -0.07 (-0.03%)
As of 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PEN vs. PHG, ZBH, SOLV, SNN, GKOS, STVN, BLCO, INSP, NARI, and PRCT

Should you be buying Penumbra stock or one of its competitors? The main competitors of Penumbra include Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Smith & Nephew (SNN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

Penumbra vs.

Koninklijke Philips (NYSE:PHG) and Penumbra (NYSE:PEN) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, community ranking, media sentiment and dividends.

Penumbra has a net margin of 2.97% compared to Koninklijke Philips' net margin of -1.83%. Koninklijke Philips' return on equity of 10.11% beat Penumbra's return on equity.

Company Net Margins Return on Equity Return on Assets
Koninklijke Philips-1.83% 10.11% 4.12%
Penumbra 2.97%8.99%6.80%

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 5.0% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Koninklijke Philips has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500.

Penumbra received 445 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 80.31% of users gave Penumbra an outperform vote while only 56.56% of users gave Koninklijke Philips an outperform vote.

CompanyUnderperformOutperform
Koninklijke PhilipsOutperform Votes
375
56.56%
Underperform Votes
288
43.44%
PenumbraOutperform Votes
820
80.31%
Underperform Votes
201
19.69%

Penumbra has a consensus price target of $261.36, indicating a potential downside of 2.64%. Given Penumbra's stronger consensus rating and higher probable upside, analysts plainly believe Penumbra is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20
Penumbra
0 Sell rating(s)
4 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.81

Penumbra has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke Philips$19.66B1.27-$503.27M-$0.42-63.21
Penumbra$1.06B9.73$90.95M$0.86312.15

In the previous week, Penumbra had 1 more articles in the media than Koninklijke Philips. MarketBeat recorded 8 mentions for Penumbra and 7 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 0.63 beat Penumbra's score of 0.43 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Koninklijke Philips
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Penumbra
0 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Penumbra beats Koninklijke Philips on 15 of the 19 factors compared between the two stocks.

Get Penumbra News Delivered to You Automatically

Sign up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PEN vs. The Competition

MetricPenumbraSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$10.30B$4.83B$5.40B$20.05B
Dividend YieldN/A52.58%5.37%3.61%
P/E Ratio312.1526.8888.9741.75
Price / Sales9.7361.111,285.7917.51
Price / Cash93.2550.8936.6017.54
Price / Book8.797.904.965.86
Net Income$90.95M$13.87M$117.96M$1.01B
7 Day Performance5.82%4.26%2.58%3.59%
1 Month Performance10.68%11.34%3.53%6.09%
1 Year Performance7.25%33.35%27.05%20.27%

Penumbra Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PEN
Penumbra
3.908 of 5 stars
$268.45
+1.8%
$261.36
-2.6%
+5.5%$10.30B$1.06B312.154,200Analyst Forecast
News Coverage
Gap Up
PHG
Koninklijke Philips
2.9821 of 5 stars
$25.61
-0.8%
N/A+10.7%$24.07B$18.04B-60.9778,200
ZBH
Zimmer Biomet
4.7197 of 5 stars
$105.52
+0.9%
$123.33
+16.9%
-11.1%$21.01B$7.60B20.0618,000News Coverage
SOLV
Solventum
0.5224 of 5 stars
$68.47
+2.1%
$68.29
-0.3%
N/A$11.83B$8.26B0.0022,000
SNN
Smith & Nephew
1.8778 of 5 stars
$24.03
+0.3%
N/A-10.1%$10.51B$5.64B12.2618,452
GKOS
Glaukos
3.7598 of 5 stars
$153.23
-2.1%
$147.75
-3.6%
+71.5%$8.45B$360.35M-50.74780
STVN
Stevanato Group
N/A€22.29
-2.8%
N/A-18.8%$6.59B$1.09B47.435,635Gap Up
BLCO
Bausch + Lomb
3.0594 of 5 stars
$17.36
-2.3%
$20.58
+18.6%
+19.0%$6.11B$4.68B-16.5313,300News Coverage
INSP
Inspire Medical Systems
4.8761 of 5 stars
$179.98
-11.1%
$233.58
+29.8%
-11.4%$5.39B$755.59M168.211,011Analyst Forecast
High Trading Volume
NARI
Inari Medical
1.6904 of 5 stars
$79.32
+0.0%
$68.00
-14.3%
+38.4%$4.64B$574.50M-58.76800
PRCT
PROCEPT BioRobotics
3.0817 of 5 stars
$81.35
-6.3%
$97.86
+20.3%
+66.9%$4.25B$199.84M-41.72430News Coverage

Related Companies and Tools


This page (NYSE:PEN) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners